Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Using an index divisor in calculations helps maintain consistent measurements when prices or shares change, enabling fair comparisons.
22,619 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
A single earnings report is not the end of a story, but it can rewrite it. This article explains how Micron's latest ...
Kratos Defense Security Solutions stock is on the move as defense spending and drone capabilities gain momentum. This...
When a chief financial officer sells a large block of stock, investors sit up and take notice. This article breaks do...
July markets bring attention to enduring brands and steady income. Coca-Cola's blend of dividend discipline, pricing ...
Sam Altman is driving OpenAI toward a trillion-dollar target, while SoftBank faces a substantial loan due in 2027. Th...
When a career hits its peak, money, fame, and pressure can collide. This article uses parsons says ‘miserable’ peak a...
Investing in tomorrow’s energy tech can feel risky. This article outlines how a compact, early-stage stock could grow...
Powell Industries stock soars after a significant stake increase by a prominent fund, driving a 161% annual gain. Thi...
Looking for cash flow that lasts through retirement without chasing risky yields? Meet two resilient dividend stalwar...
Oracle stock swung wildly last month as AI hype collided with fundamentals. This guide explains what happened, why it...
The EV market is crowded with flashy startups, but one established leader keeps delivering durable gains. Learn why t...